Chemistry Wealth Management’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$965K Sell
2,554
-7
-0.3% -$2.81K 0.15% 91
2026
Q1
$793K Buy
2,561
+30
+1% +$9.87K 0.14% 93
2025
Q4
$876K Sell
2,531
-118
-4% -$42.2K 0.16% 88
2025
Q3
$874K Sell
2,649
-23
-0.9% -$7.06K 0.17% 85
2025
Q2
$737K Buy
2,672
+216
+9% +$46.9K 0.16% 89
2025
Q1
$411K Buy
2,456
+21
+0.9% +$4.45K 0.1% 114
2024
Q4
$565K Buy
2,435
+408
+20% +$75.5K 0.13% 95
2024
Q3
$350K Sell
2,027
-63
-3% -$10.1K 0.08% 125
2024
Q2
$336K Buy
2,090
+80
+4% +$11.2K 0.09% 125
2024
Q1
$266K Sell
2,010
-40
-2% -$4.96K 0.07% 138
2023
Q4
$229K Buy
+2,050
New +$194K 0.07% 138

Other funds holding AVGO

Chemistry Wealth Management's AVGO Position: Q2 2026 in Review

Chemistry Wealth Management reduced its Broadcom (AVGO) stake by 0.27% in Q2 2026, selling an estimated $2.81K and leaving 2,554 shares worth $965K. The position accounts for 0.15% of the portfolio, ranked #91.

Chemistry Wealth Management first reported a position in AVGO in Q4 2023 and has held it in 11 quarters since. 2,466 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • Chemistry Wealth Management held 2,554 shares of Broadcom worth $965K as of Q2 2026.
  • Chemistry Wealth Management sold 7 Broadcom shares in Q2 2026, an estimated $2.81K.
  • Broadcom made up 0.15% of Chemistry Wealth Management's portfolio in Q2 2026, its #91 holding.
  • Chemistry Wealth Management first reported a position in Broadcom in Q4 2023 and has held it in 11 quarters since.
  • 2,466 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.